Top

Published in:

22-09-2022 | Original Research

Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020

Authors: Daniel M. Walker, PhD, MPH, Christine M. Swoboda, PhD, Karen Shiu-Yee, PhD, MPH, Willi L. Tarver, DrPH, MLIS, Timiya S. Nolan, PhD, Joshua J. Joseph, MD, MPH

Published in: Journal of General Internal Medicine | Issue 4/2023

Abstract

Background

Clinical trial diversity is critical to advance health and health equity. Research addressing the discrepancy between goals of achieving clinical trial diversity and realities of study enrollment remains underdeveloped.

Objective

This study aims to examine the association between race/ethnicity and clinical trial invitation, participation, knowledge, and sources of influence on clinical trial participation.

Design and Participants

A cross-sectional, observational study using nationally representative data from 3689 US adults (≥ 18 years of age) who responded to the Health Information National Trends Survey fielded from February 24 to June 15, 2020.

Main Measures

Primary outcomes included clinical trial invitation, participation, knowledge, and sources of influence on participation. The independent variable of interest is self-reported race/ethnicity.

Key Results

Respondents identifying as non-Hispanic Black (relative to non-Hispanic White) had higher odds of being invited into a clinical trial (adjusted odds ratio: 2.0, 95% confidence interval (CI): 1.1, 3.7), but no differences in odds of participation were observed by race/ethnicity. Respondents from all races/ethnicities reported that personal healthcare providers were the most trusted source of clinical trial information. Hispanic (marginal effect (ME): − 0.09; 95% CI: − 0.16, − 0.03), non-Hispanic Black (ME: − 0.11; 95% CI: − 0.18, − 0.04), and non-Hispanic other (ME: − 0.11; 95% CI: − 0.19, − 0.02) respondents had lower odds than non-Hispanic White respondents of saying they would be influenced “a lot” by their doctor encouraging participation. Non-Hispanic Black respondents had significantly lower odds (relative to non-Hispanic White) of indicating family encouragement would influence their clinical trial participation decision “a lot” (ME: − 0.09; 95%: CI: − 0.14, − 0.03).

Conclusion

While personal healthcare providers were trusted sources of information, racial/ethnic minority populations noted lower odds of clinical trial participation influence from providers and family. Thus, it is imperative for the healthcare, government, and industry organizations to build trust in medicine and science.

Available only for authorised users

Knepper TC, McLeod HL. When will clinical trials finally reflect diversity? Nature. 2018;557(7704):157-159. https://doi.org/10.1038/d41586-018-05049-5CrossRefPubMed

U.S. Census Bureau. Quickfacts: United States. Accessed January 18, 2022. https://www.census.gov/quickfacts/fact/table/US/RHI825219

U.S. Food and Drug Administration. 2020 drug trials snapshots: summary report; 2021. Accessed January 15, 2022. https://www.fda.gov/media/145718/download

Holt HK, Gildengorin G, Karliner L, Fontil V, Pramanik R, Potter MB. Differences in hypertension medication prescribing for Black Americans and their association with hypertension outcomes. J Am Board Fam Med. 2022;35(1):26-34. https://doi.org/10.3122/jabfm.2022.01.210276CrossRefPubMed

Gopal DP, Okoli GN, Rao M. Re-thinking the inclusion of race in British hypertension guidance. J Hum Hypertens. 2022;36(3):333-335. https://doi.org/10.1038/s41371-021-00601-9CrossRefPubMed

Wright JT. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293(13):1595. https://doi.org/10.1001/jama.293.13.1595CrossRefPubMed

Ortega RF, Yancy CW, Mehran R, Batchelor W. Overcoming lack of diversity in cardiovascular clinical trials: a new challenge and strategies for success. Circulation. 2019;140(21):1690-1692. https://doi.org/10.1161/CIRCULATIONAHA.119.041728CrossRefPubMed

Doubeni CA, Simon M, Krist AH. Addressing systemic racism through clinical preventive service recommendations from the US Preventive Services Task Force. JAMA. 2021;325(7):627. https://doi.org/10.1001/jama.2020.26188CrossRefPubMed

Unger JM, Cook E, Tai E, Bleyer A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book. 2016;(36):185-198. https://doi.org/10.1200/EDBK_156686CrossRef

10.

Niranjan SJ, Wenzel JA, Martin MY, et al. Perceived institutional barriers among clinical and research professionals: minority participation in oncology clinical trials. JCO Oncol Pract. 2021;17(5):e666-e675. https://doi.org/10.1200/OP.20.00970CrossRefPubMedPubMedCentral

11.

Kahn JM, Gray DM, Oliveri JM, Washington CM, DeGraffinreid CR, Paskett ED. Strategies to improve diversity, equity, and inclusion in clinical trials. Cancer. 2022;128(2):216-221. https://doi.org/10.1002/cncr.33905CrossRefPubMed

12.

National Institutes of Health. All of Us Research Program. Published 2022. Accessed January 15, 2022. https://allofus.nih.gov

13.

U.S. Department of Health and HUman Services, Office of Inspector General. NIH’s oversight processes to ensure diversity among human subjects enrolled in clinical trials. Published July 2021. Accessed January 15, 2022. https://oig.hhs.gov/reports-and-publications/workplan/summary/wp-summary-0000605.asp

14.

Causey M. NIH affirms importance of diversity in clinical trial workforce. The Association of Clinical Research Professionals. Published October 19, 2021. Accessed January 10, 2022. https://acrpnet.org/2021/10/19/nih-affirms-importance-of-diversity-in-clinical-trial-workforce/

15.

Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Enhancing the diversity of clinical trial populations -eligibility criteria, enrollment practices, and trial designs guidance: guidance for industry. U.S. Department of Health and Human Services; 2020. Accessed January 12, 2022. https://www.fda.gov/media/127712/download

16.

National Cancer Institute. Health Information National Trends Survey. Published 2021. Accessed January 15, 2022. https://hints.cancer.gov

17.

Westat. Health Information National Trends Survey 5 (HINTS 5): Cycle 4 Methodology Report. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services; 2020. Accessed January 18, 2022. https://hints.cancer.gov/docs/methodologyreports/HINTS5_Cycle4_MethodologyReport.pdf

18.

Dillman DA. The design and administration of mail surveys. Annu Rev Sociol. 1991;17(1):225-249. https://doi.org/10.1146/annurev.so.17.080191.001301CrossRef

19.

Moser R, Naveed S, Cantor D, et al. Integrative Analytic Methods Using Population-Level Cross-Sectional Data. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services; 2013. Accessed January 18, 2022. https://hints.cancer.gov/docs/HINTS_IDA_Report.pdf

20.

Gray DM, Nolan TS, Gregory J, Joseph JJ. Diversity in clinical trials: an opportunity and imperative for community engagement. Lancet Gastroenterol Hepatol. 2021;6(8):605-607. https://doi.org/10.1016/S2468-1253(21)00228-4CrossRefPubMed

21.

Wenzel JA, Mbah O, Xu J, et al. A model of cancer clinical trial decision-making informed by African-American cancer patients. J Racial Ethn Health Disparities. 2015;2(2):192-199. https://doi.org/10.1007/s40615-014-0063-xCrossRefPubMedPubMedCentral

22.

Clark LT, Watkins L, Piña IL, et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Prob Cardiol. 2019;44(5):148-172. https://doi.org/10.1016/j.cpcardiol.2018.11.002CrossRef

23.

Smirnoff M, Wilets I, Ragin DF, et al. A paradigm for understanding trust and mistrust in medical research: the Community VOICES study. AJOB Empir Bioeth. 2018;9(1):39-47. https://doi.org/10.1080/23294515.2018.1432718CrossRefPubMedPubMedCentral

24.

Eaton LA, Driffin DD, Kegler C, et al. The role of stigma and medical mistrust in the routine health care engagement of Black men who have sex with men. Am J Public Health. 2015;105(2):e75-e82. https://doi.org/10.2105/AJPH.2014.302322CrossRefPubMedPubMedCentral

25.

Brincks AM, Shiu-Yee K, Metsch LR, et al. Physician mistrust, medical system mistrust, and perceived discrimination: associations with HIV care engagement and viral load. AIDS Behav. 2019;23(10):2859-2869. https://doi.org/10.1007/s10461-019-02464-1CrossRefPubMedPubMedCentral

26.

Pahus L, Suehs CM, Halimi L, et al. Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials? BMC Med Ethics. 2020;21(1):72. https://doi.org/10.1186/s12910-020-00509-yCrossRefPubMedPubMedCentral

27.

Fisher JA. Institutional mistrust in the organization of pharmaceutical clinical trials. Med Health Care Philos. 2008;11(4):403-413. https://doi.org/10.1007/s11019-008-9154-yCrossRefPubMedPubMedCentral

28.

Borno HT, Andemeskel G, Palmer NR. Redefining attribution from patient to health system—how the notion of “mistrust” places blame on Black patients. JAMA Oncol. 2021;7(5):780. https://doi.org/10.1001/jamaoncol.2020.8482CrossRefPubMed

29.

Gray DM, Nolan TS, Bignall ONR, Gregory J, Joseph JJ. Reckoning with our trustworthiness, leveraging community engagement. Population Health Management. Published online July 16, 2021:pop.2021.0158. https://doi.org/10.1089/pop.2021.0158

30.

Joseph JJ, Glover A, Olayiwola JN, et al. Mask up: academic-community-government partnerships to advance public health during COVID-19. Population Health Management. Published online January 8, 2021:pop.2020.0305. https://doi.org/10.1089/pop.2020.0305

31.

De las Nueces D, Hacker K, DiGirolamo A, Hicks LS. A systematic review of community-based participatory research to enhance clinical trials in racial and ethnic minority groups. Health Serv Res. 2012;47(3 Pt 2):1363-1386. https://doi.org/10.1111/j.1475-6773.2012.01386.xCrossRefPubMedCentral

32.

Andrasik MP, Broder GB, Wallace SE, et al. Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment. Newman PA, ed. PLoS ONE. 2021;16(10):e0258858. https://doi.org/10.1371/journal.pone.0258858CrossRefPubMedPubMedCentral

33.

Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-2615. https://doi.org/10.1056/NEJMoa2034577CrossRefPubMed

34.

Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403-416. https://doi.org/10.1056/NEJMoa2035389CrossRefPubMed

35.

Joseph JJ, Nolan TS, Williams A, et al. Improving cardiovascular health in Black men through a 24-week community-based team lifestyle change intervention: the Black Impact pilot study. Am J Prev Cardiol. Published online January 2022:100315. https://doi.org/10.1016/j.ajpc.2022.100315

36.

Brewer LC, Balls-Berry JE, Dean P, Lackore K, Jenkins S, Hayes SN. Fostering African-American Improvement in Total Health (FAITH!): an application of the American Heart Association’s Life’s Simple 7^TM among Midwestern African-Americans. J Racial Ethn Health Disparities. 2017;4(2):269-281. https://doi.org/10.1007/s40615-016-0226-zCrossRefPubMed

37.

Brewer LC, Hayes SN, Jenkins SM, et al. Improving cardiovascular health among African-Americans through mobile health: the FAITH! App Pilot Study. J Gen Intern Med. 2019;34(8):1376-1378. https://doi.org/10.1007/s11606-019-04936-5CrossRefPubMedPubMedCentral

38.

Nolan TS, Bell AM, Chan Y, Leak Bryant A, Bissram JS, Hirschey R. Use of video education interventions to increase racial and ethnic diversity in cancer clinical trials: a systematic review. Worldviews Evid Based Nurs. 2021;18(5):302-309. https://doi.org/10.1111/wvn.12539CrossRefPubMedPubMedCentral

Title: Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020
Authors: Daniel M. Walker, PhD, MPH
Christine M. Swoboda, PhD
Karen Shiu-Yee, PhD, MPH
Willi L. Tarver, DrPH, MLIS
Timiya S. Nolan, PhD
Joshua J. Joseph, MD, MPH
Publication date: 22-09-2022
Publisher: Springer International Publishing
Published in: Journal of General Internal Medicine / Issue 4/2023
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-022-07780-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Design and Participants

Main Measures

Key Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2023

Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness

We Built it, But Did They Come: Veterans’ Use of VA Healthcare System-Provided Complementary and Integrative Health Approaches

Effects of Health Information Exchanges in the Adult Inpatient Setting: a Systematic Review

Musical Expression as a Healing Art

Associations Between General Vaccine Hesitancy and Healthcare Access Among Arkansans

Where Do Real-Time Prescription Benefit Tools Fit in the Landscape of High US Prescription Medication Costs? A Narrative Review

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials